Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Open-market sale Director sold 77,302 shares at an average $0.55 ($42,540)
  2. 4 Shares withheld for taxes See Remarks gave up 1,714 shares (to pay taxes)
  3. 4 Shares withheld for taxes See Remarks gave up 1,632 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 4,545 shares (to pay taxes)
  5. 4 Shares withheld for taxes See Remarks gave up 1,714 shares (to pay taxes)
  6. 4 Grant or award Director acquired 9,000 shares (grant or award)
  7. 4 Grant or award Director acquired 9,000 shares (grant or award)
  8. 4 Grant or award Director acquired 9,000 shares (grant or award)
  9. 4 Shares withheld for taxes See Remarks gave up 8,032 shares (to pay taxes)
  10. 4 Shares withheld for taxes See Remarks gave up 7,534 shares (to pay taxes)
  11. 4 Grant or award Director acquired 9,000 shares (grant or award)
  12. 4 Shares withheld for taxes Chief Executive Officer gave up 21,094 shares (to pay taxes)
  13. 4 Grant or award Director acquired 9,000 shares (grant or award)
  14. 4 Grant or award Director acquired 9,000 shares (grant or award)
  15. 4 Shares withheld for taxes See Remarks gave up 8,032 shares (to pay taxes)
  16. 4 Grant or award See Remarks acquired 10,000 shares (grant or award)
  17. 4 Grant or award Director acquired 150,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 3,108 shares (grant or award)
  20. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $1.40 ($27,922)

Page 10 of 33 · 648 filings